Request a quote

Request a quote

Drug Delivery

MDI, DPI, nebulizer, and nasal-spray performance per USP & EP.

MDI Inhalers DPI Inhalers Nebulizers Other Drug Delivery Nasal Spray Devices Browse all →

Air Treatment

Room air cleaners, in-line duct filtration, UV/UVGI, filter media.

In-Line Duct Systems Room Purifiers Large Air Cleaners UV / UVGI Devices Other Air Treatment Filter Media Browse all →

Spray & Aerosol

Consumer and industrial sprays, foggers, pump and pressurized formats.

Industrial Sprays Consumer Sprays Pump Sprays Oral Sprays Powder Sprays Other Pressurized Area Foggers Fire Suppression Browse all →

Respiratory

Masks, respirators, PAP devices, anesthesia systems, and breathing-pathway testing.

Masks & Respirators CPAP / BiPAP / PAP Anesthesia Machines Browse all →

Medical Devices

Sterile packaging, particle-emitting equipment, and bioaerosol monitors.

Sterile Packaging Particle Emissions Biodetectors Browse all →

Surface & Antimicrobial

Treated hard surfaces, antimicrobial fabrics and textiles, and medical-device surface treatment.

Hard Surfaces Fabrics & Textiles Surface Treatment Browse all →

Research

Case studies

Work you can examine.

All case studies →

Inhalation & Drug Delivery

Studies of dose delivery, deposition, and device performance for inhaled and nasal products.

Dry-Powder Nasal Spray Testing: Phase 1 Characterization Browse all →

Aerosol Characterization

Studies that measure aerosol size, persistence, plume behavior, and related physical properties.

Fragrance aerosols: particle size and chamber counts Browse all →

Exposure Assessment

Studies that connect measured aerosols with bounded exposure and risk questions.

Prop 65 TiO2 Testing for Cosmetic Powders Browse all →

Packaging & Stability

Studies of packaging behavior under controlled storage and environmental conditions.

Cosmetic wand-package testing: temperature and altitude Browse all →

Air-Cleaner Performance

Controlled and field studies of air-cleaning devices and bioaerosol performance.

First-Minute Bioaerosol Testing for Active-in-Air Devices School Air Purifier Field Study: Bioaerosols and Absenteeism Glow Guardian Air-Purifying Candle: Concept to Market Browse all →

Aerosol Science

Practical explainers for aerosol behavior, particle sizing, bioaerosol generation, and test scoping.

Aerosol Science Basics Bioaerosol Generation & Sampling Spray & Plume Dynamics Understanding Particle Size Browse all →

Inhalation

Reference science for orally inhaled and nasal drug products (OINDP): pulmonary drug delivery, aerodynamic particle sizing, and inhaler, nebulizer, and nasal-spray performance characterization.

Aerodynamic Particle Size Distribution (APSD) Testing Pulmonary Drug Delivery Browse all →

Regulatory Guidance

Regulatory and standards context for stability, validation, documentation, and method decisions.

AHAM AC-1 / AC-5 Standards Cost of Unsubstantiated Antimicrobial and Air Claims ASHRAE 241 Infection Risk Mitigation FDA Inhalation Device Guidance GLP vs. GMP: What's the Difference?ICH Q1A(R2) Stability Guidelines ISO 17025 Accreditation Explained What an EPA GLP Inspection Means for Study Sponsors Browse all →

Filtration

Filter ratings, gas-phase removal, room-air-cleaner claims, and performance terminology.

Filter Types & Mechanisms Gas-Phase and VOC Filtration HEPA vs. ULPA Filters MERV Ratings Explained Browse all →

Disinfection

UVGI, antimicrobial, surface, and biofilm claim context for test planning.

Antimicrobial Testing Methods Biofilm Science Surface Disinfectant Claims UV / UVGI Disinfection Browse all →

ARE LABS / RESEARCH

Real studies.
Evidence you can examine.

Explore the questions we investigated, the measurements we made and what the results mean for product development.

The study library

2 studies found

Inhalation & Drug Delivery

Dry-Powder Nasal Spray Testing: Phase 1 Characterization

The study established an early performance baseline for comparing the two variants and provided data for a regulatory-facing Phase 1 characterization package. It did not assess clinical efficacy or support claims of approval.

Selected findingRecovered material was predominantly classified in the nasal or upper-airway region for both variants.

Air-Cleaner Performance

First-Minute Bioaerosol Testing for Active-in-Air Devices

The method addressed a product-mechanism question that standard chamber decay testing does not isolate: what viable bioaerosol concentration remains one minute after a new challenge enters room air that has already been treated?

Selected findingThe method compared viable bioaerosol concentration after a one-minute post-aerosolization mixing period in matched control and pretreated-room conditions.